Back

Antihypertensive treatment and erectile dysfunction: a penile Doppler ultrasound study

30 August 2016 (16:48 - 16:57)
Organised by:
Congress Presentation Part of: Hypertension in special conditions Treatment of hypertension ESC Premium Access ESC Congress 2016

About the speaker

Photo
Mr Nikolaos Ioakeimidis

University of Athens, Athens (Greece)

9 More presentations in this session

Presentation thumbnail
Long-term outcome of surgically- and medically-treated primary aldosteronism (PA) in the PA Prevalence in hYpertensives (PAPY) Study
Professor G. Rossi (Padua, IT)
Abstract
Presentation thumbnail
Hypertensive crises treatment in the real-world: are anti-anxiety drugs effective anti-hypertensive agents?
Associate Professor S. Perlini (Pavia, IT)
Abstract Slides Video
Presentation thumbnail
Blood pressure and mortality outocomes in hypertnesive patients with mild chronic obstructive pulmonary disease.
Mr K. Bryniarski (Krakow, PL)
Abstract Slides Video
Presentation thumbnail
Urapidil is more effective than nitroglycerin in maintaining renal blood flow in patients with hypertensive urgencies.
Associate Professor Y. Lutay (Kiev, UA)
Abstract Slides Video
Presentation thumbnail
Increased left ventricular mass independent of blood pressure in women with a history of hypertensive pregnancy
Doctor H. Boardman (Oxford, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Hypertension in special conditions

The Event

Event poster

ESC Congress 2016

30 August 2016 16:48 CET
You may be interested in
thumbnail
Congress Presentation
Erectile dysfunction, generalized vascular disease and the long term effects of smoking exposure on arterial properties: time is of the essence
28 August 2022
thumbnail
Congress Presentation
Introduction
30 August 2025
thumbnail
Congress Presentation
Instrumental evaluation of mild cognitive decline in hypertensive patients: the role of transcranial doppler
29 June 2021
thumbnail
Congress Presentation
Efficacy and safety of various doses of the new dual endothelin receptor antagonist aprocitentan in the treatment of hypertension
31 August 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources